Skip to main content
Log in

The influence of high doses of oral medroxyprogesterone acetate on glucose tolerance, serum insulin levels and adrenal response to ACTH

A study of 17 patients under treatment for endometrial cancer

  • Published:
Archives of gynecology Aims and scope Submit manuscript

Summary

Seventeen women aged 55 to 76 years who had been treated for endometrial cancer by surgery or radiotherapy or a combination of both were given 300 mg of medroxyprogesterone acetate (MPA) daily by mouth. Before treatment and again during the 3rd week of treatment an oral glucose tolerance test (with measurement of serum insulin levels) and an ACTH-stimulation test were done. All blood glucose levels tended to be higher with MPA therapy and serum insulin levels were significantly increased 3 h after a glucose load. The rise of serum cortisol 30 min after ACTH-stimulation was significantly less with MPA therapy. Oral MPA thus appeared to have a glucocorticoid-like action.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Beck P (1969) Effects of gonadal hormones and contraceptive steroids on glucose and insulin metabolism. In: Salhanick HS, Kipnis DM, Vande Wiele RL (eds) Metabolism effects of gonadal hormones and contraceptive steroids. Plenum Press, New York London, pp 97–125

    Google Scholar 

  2. Beck P (1970) Comparison of the metabolic effects of chlomadinone acetate and conventional contraceptive steroids in man. J Clin Endocrin 30: 785

    Google Scholar 

  3. Beck P, Venable RL, Hoff DL (1975) Mutual modification of glucose-stimulated serum insulin responses in female rhesus monkeys by ethinyl estradiol and nortestosterone derivatives, J Clin Endocrinol Metab 41: 44–53

    PubMed  Google Scholar 

  4. Bottermann P, Dieterle P, Hochheuser W, Hörn K, Kopetz K, Schleypen K, Schwarz K, Scriba PC (1967) Zur Frage der endokrinen Nebenwirkungen von Ovulationshemmern. Münch Med Wochenschr 109: 685–691

    Google Scholar 

  5. Camanni F, Massara F, Molinatti GM (1963) The cortisone-like effect of 6-alpha-methyl-17-alpha-acetoxyprogesterone in the adrenalectomized man. Acta Endocrinol 43: 477–483

    PubMed  Google Scholar 

  6. Di Paola G, Puchulu F, Robin M, Nicholson R, Hart M (1968) Oral contraceptives and carbohydrate metabolism. Am J Obstet Gynecol 101: 206–216

    PubMed  Google Scholar 

  7. Di Paola G, Robin M, Nicholson R (1970) Estrogen therapy and glucose tolerance test. Am J Obstet Gynecol 107: 124–132

    PubMed  Google Scholar 

  8. Dhall K, Kumar M, Rastogi GK, Devi PK (1977) Short-term effects of norethisterone oenanthate and medroxyprogesterone acetate on glucose, insulin, growth hormone, and lipids. Fertil Steril 28: 156–158

    PubMed  Google Scholar 

  9. Fell BF, Campbell RM, Dinsdale D (1977) Adrenocortical involution in rats during oestrous synchronisation with medroxyprogesterone. Res Vet Sci 22 (3): 316–323

    PubMed  Google Scholar 

  10. Frerichs H, Grote S, Severidt E, Creutzfeld W (1966) 12. Symp d Dtsch Ges f Endocrin und 2. Tagung d Dtsch Diabetes-Ges, Wiesbaden 21.–23. 4. 1966

  11. Glenn EM, Richardson SL, Bowman BJ (1959) Biologic activity of 6-alpha-methyl compounds corresponding to progesterone, 17-alpha-hydroxy-progesterone acetate and compounds. Metabolism 8: 265–285

    PubMed  Google Scholar 

  12. Holub DA, Katz FH, Jailer JW (1961) Inhibition by 6-methyl-a-acetory-progesterone of ACTH synthesis and release in the rat. Endocrinology 68: 173

    PubMed  Google Scholar 

  13. D'Malley BW, Sherman MR, Toft DO, Spelsberg TC, Schreder WT, Steggles AW (1970) A specific oviduct target-tissue receptor for progesterone, Identification characterization, partial purification, inter-compartmental transfer kinetics and specific interaction with the genome. Adv Biosciences 7: 213–234

    Google Scholar 

  14. Pi-Sunyer FX, Oster St, (1968) Effect of an ovulatory suppressant on glucose tolerance and insulin secretion. Obstet Gyncol 31: 482

    Google Scholar 

  15. Spellacy WN, Carlson KL, Birk SA, Schade SL (1968) Glucose and insulin alterations after one year of combination-type oral contraceptive treatment. Metabolism 17: 496–501

    PubMed  Google Scholar 

  16. Spellacy WN (1969) A review of carbohydrate metabolism and the oral contraceptives. Am J Obstet Gynecol 104: 448–460

    PubMed  Google Scholar 

  17. Spellacy WN, Buhi WC, Bendel RP (1969) Insulin and glucose studies after one year of treatment with a sequential-type oral contraceptive. Obstet Gynecol 33: 800–804

    PubMed  Google Scholar 

  18. Spellacy WN, McLeod AGW, Buhi WC, Birk SA, McCreary BS (1970) Medroxyprogesterone acetate and carbohydrate metabolism: measurement of glucose, insulin, and growth hormone during 6 month's time. Fertil Steril 21: 457

    PubMed  Google Scholar 

  19. Tausk M (1979) Pharmakologie der Hormone. Thieme, Stuttgart

    Google Scholar 

  20. Tyler ET (1970) Present status of injectable contraceptives: results of seven-years study. Fertil Steril 21: 469

    PubMed  Google Scholar 

  21. Vermeulen A, Daneels R, Thiery M (1970) Effects of oral contraceptives on carbohydrate metabolism. Diabetologia 6: 519–523

    PubMed  Google Scholar 

  22. Wynn V, Doar JWH (1969) Some effects of oral contraceptives on carbohydrate metabolism. Lancet 2: 761–766

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leis, D., Bottermann, P., Ermler, R. et al. The influence of high doses of oral medroxyprogesterone acetate on glucose tolerance, serum insulin levels and adrenal response to ACTH. Arch. Gynecol. 230, 9–13 (1980). https://doi.org/10.1007/BF02108593

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02108593

Key words

Navigation